Guangdong Zhongsheng Pharmaceutical Co., Ltd.
002317.SZ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$19.55B
Close$
$1.63
93.6% downside
Current Fair Value
93.6% downsideOvervalued by 93.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $19.55 Billion |
|---|---|
| Enterprise Value | $18.92 Billion |
| Annual dividend | $0.20 |
| Dividend yield | 0.78% |
| Earnings per Share | $0.33 |
| Beta | 0.6 |
| Outstanding Shares | 849,930,477 |
Return
| Return on Equity | 4.95% |
|---|---|
| Return on Assets | 3.93% |
| Return on Invested Capital | 5.59% |
Valuation & Multiples
| P/E Ratio | 106.74 |
|---|---|
| PEG | 2703.41 |
| Price to Sales | 12.84 |
| Price to Book Ratio | 6.42 |
| Enterprise Value to Revenue | 9 |
| Enterprise Value to EBIT | 76.91 |
| Enterprise Value to Net Income | 93 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 2, 2026
EPS
$0.08
Est. $0.10Revenue
$463.31 M
Est. $510.04 MNext Earnings Call
Expected Date
April 27, 2027
EPS Estimate
$0.13
Consensus analyst estimateRevenue Estimate
$680.06 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Guangdong Zhongsheng Pharmaceutical Co., Ltd.
1,757 employees
CEO: Yong Hong Chen
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio ...